Finally, overexpression of miR-24-1 suppressed tumor growth of RCC in an animal xenograft model, yet enhancer depletion led to loss of function of miR-24-1, suggesting that reactivation of FBP1 by miR-24-1 relies on enhancer integrity and can provide a potential treatment strategy for RCC. This evidence concerns the gene FBP1 and neoplasm.